100 Abbott Park Road
Tel: (224) 667-6100
About Abbott Laboratories
Abbott has facilities in more than 40 countries and markets its products in more than 130 countries. More than 60,000 Abbott employees around the world have devoted their careers to advancing the practice of health care. The largest concentration of Abbott employees is in Lake County, Ill., home to both corporate headquarters at Abbott Park and the company's principal manufacturing location at North Chicago. Still, less than one-third of all Abbott employees are located in Illinois. The majority of our employees are spread across the United States and around the world.
Abbott is building a global portfolio around two key groups - pharmaceuticals and medical products - that form a strategically cohesive business mix.
Our Pharmaceutical Products Group strives to consistently discover, develop and market breakthrough drugs that improve patient health, especially in areas of unmet medical need. The group's primary focus is on translating innovative science into effective medicine and spans several areas, including the Pharmaceutical Products Division, the Nutritionals Division and Abbott International, as well as TAP Pharmaceuticals Inc., Abbott's joint venture with Takeda Chemical Industries, Ltd.
Our Medical Products Group is building leading businesses in hospital based medicines and devices, diagnostic tests and instruments, and nutritionals for adults and children, while identifying ways to promote health through the linkage of drugs, devices, diagnostics and nutritional products.
There's a world of inspiration that you can only get from being a part of the Abbott team. That's because we are made up of people who are passionate about life, health care and the contributions they can make.
For over a century, innovation and success in the areas of pharmaceuticals, nutritionals and diagnostics has enabled Abbott to provide total, integrated solutions for some of the world's most prevalent medical conditions, including: AIDS, cancer and diabetes.
Abbott technologies span the health care spectrum and play a key role in the way people get well and stay healthy. And with $22 billion in sales in more than 130 countries, we don't just see a better world - we're positioned to make it happen.
Founder: Wallace Calvin Abbott
CEO: Miles White
CFO: Brain Yoor
Tweets by Abbott
1335 articles with Abbott Laboratories
Alexander (Sasha) Opotowsky, associate professor at Harvard Medical School and a cardiologist at Boston Children’s Hospital and Brigham and Women’s Hospital took time out to speak with BioSpace about advances in heart health, congenital heart disease (CHD), biopharma, and the Adult Congenital Hea...
The area is home to numerous well-known players in the pharma industry, including Abbott, Iovance, Gossamer Bio, Crown Biosciences, Illumina, Human Longevity and many, many more.
Companies are filling in the gaps and the entire area of so-called “liquid biopsies” is hot these days, with companies like Guardant Health, Karius, Freenome, Apostle and GRAIL Bio entering the market. With this backdrop, let’s look at some companies working in the same field as the now-defunct T...
“Humira is an anti-TNF monoclonal antibody that currently treats Crohn's disease, rheumatoid arthritis, ulcerative colitis, hidradenitis suppurativa, psoriasis, psoriatic arthritis, juvenile idiopathic arthritis, ankylosing spondylitis and uveitis,” quotes Humira developer AbbVie’s website. Those...
11/14/2018The fund will be administered through the Ventura County Community Foundation. Officials indicate that 100 percent of the funds will go to help victims’ families. The Foundation is calling for additional donations.
10/22/2018Execs at Novo Nordisk, AbbVie, and more made moves this week. Here's a roundup of those changes.
Forbes came out with its ranking of the World’s Best Employers 2018, with a number of global biopharmaceutical companies ranked high on the list. Here’s the top 10 in that category.
Personalized medicine continues to grow in importance, and having the ability to monitor health data has proven to be a significant desire for people as the number of wearable devices continues to grow.
Thomson Reuters recently announced their list of the top 100 most diverse and inclusive organizations. In the top 50 of the list there are 10 biopharma and medical device companies. Let’s take a look.
It’s a busy week on the U.S. Food and Drug Administration (FDA)’s calendar, although the agency got ahead of itself and approved three of the applications early. Here’s a look.
GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today that David A. Dodd has been appointed President and Chief Executive Officer, effective September 1, succeeding Robert McNally, PhD, who has announced his retirement.
Industry veteran brings biopharma and medical device company leadership experience as SetPoint advances its proprietary bioelectronic medicine platform.
Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell and small molecule compound technologies, today announced that the Board of Directors has appointed Jim Scully as interim chief executive officer.
Abbott Laboratories(NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the FreeStyle® Libre 14 day Flash Glucose Monitoring system, which allows people with diabetes to wear the sensor up to 14 days with high accuracy.
UTILITY therapeutics signs license agreement with LEO Pharma A/S for US rights to mecillinam and pivmecillinam
UTILITY therapeutics Ltd (“UTILITY” or “the Company”), a pharmaceutical company focused on developing and commercialising antibiotics in the US, today announces the signature of an exclusive license agreement for the antibiotics mecillinam and pivmecillinam with LEO Pharma A/S.
Abbott today announced financial results for the first quarter ending March 31, 2018 and is off to a strong start to the year.
As legal battles over opioid drugs slowly move through the courts the U.S. Department of Justice is adding its weight to the matter. This week the DOJ asked the courts for permission to help settle disputes brought by state and local governments against opioid manufacturers and distributors.
- COMPANIES TO COLLABORATE ON PRODUCT DEVELOPMENT, CLINICAL TRIALS AND REGULATORY ACTIVITIES TO OBTAIN APPROVAL IN U.S. AND E.U. - AGREEMENT COMPLEMENTS AND EXTENDS ABBOTT'S BROAD LINE OF VASCULAR CARE PRODUCTS AND DEMONSTRATES VALUE OF SURMODICS' PROPRIETARY DRUG-DELIVERY AND WHOLE-PRODUCT SOLUTIONS STRATEGY
Abbott announced today the FreeStyle LibreLink app is now available in Europe for use with compatible smartphones2.
The I-Hart study, which enrolled 40 people with Type I diabetes, found that Dexcom’s device reduced patients’ time spent in hypoglycemia by 43 minutes.